They will boost Dr. Reddy’s OTC segment, which had US sales of $200 million. Photo: HTHyderabad: India’s No.2 drug maker Dr.Reddy’s Laboratories Ltd has acquired six over-the-counter (OTC) labels from US-based Ducere Pharma for an undisclosed sum. The deal, which was announced on Wednesday, marks the Indian drug maker’s entry into the highly lucrative branded US consumer health goods market. Some analysts such as Nangra, however, believe the Indian drug maker needs to invest more on brand building. Ducere acquired the six brands from Novartis in May 2013 when the Swiss pharma giant restructured its US business following regulatory issues at a plant there.

Source: Mint May 25, 2016 10:26 UTC